Leonard Davis Institute of Health Economics

Rosemary Mazanet, M.D., PhD. Joins Columbia Care's Board of Directors

Retrieved on: 
Monday, September 11, 2023
Natural Resources, Alternative Medicine, Other Manufacturing, Health, Specialty, Cannabis, Manufacturing, Retail, Columbia University, University of Southern California, Heart, Database, University, Palliative care, Wharton School of the University of Pennsylvania, Journal of Palliative Medicine, Coronavirus Scientific Advisory Board, General partnership, Human, FSE, National Institutes of Health, Bangladesh Technical Education Board, Dana–Farber Cancer Institute, Harvard Medical School, Tablet, Leonard Davis Institute of Health Economics, Journal, RAND Corporation, Clinical research, Internal medicine, Filgrastim, Knowledge, Hospital, FDA, Dana, NEO, NLRB v. Kentucky River Community Care, Inc., Chair, JAMA, Pharmaceutical industry, Management, Amgen, New York University, Brigham

Dr. Mazanet began advising Columbia Care in 2013 and then joined its Scientific Advisory Board as its Chair in 2015.

Key Points: 
  • Dr. Mazanet began advising Columbia Care in 2013 and then joined its Scientific Advisory Board as its Chair in 2015.
  • Since 2013, she has played an integral role of developing groundbreaking form factors specifically for palliative care, such as pressed tablets.
  • I know she will continue to add significant value as a member of our Board of Directors.
  • Congratulations, Rosemary and thank you," said Nicholas Vita, CEO, Columbia Care.

Executive Vice President of RWJBarnabas Health Joins Board of Directors of New Jersey Community Capital

Retrieved on: 
Tuesday, May 2, 2023
Columbia University, JPMorgan Chase, Rutgers Business School – Newark and New Brunswick, Independence Blue Cross, Transformation, University, Education, RWJBarnabas Health, Leonard Davis Institute of Health Economics, Horizon Blue Cross Blue Shield of New Jersey, University School, Philadelphia, Becker's Hospital Review, Medicare, Wharton School of the University of Pennsylvania, Case Western Reserve University School of Medicine, Public health, UnitedHealth Group, CDFI, Economic development, Widener University Commonwealth Law School, AstraZeneca, BIPOC, NJCC, Health Partners Plans, Health, Wells Fargo, Forest Law Enforcement and Governance Program, Management, Medicaid

NEW BRUNSWICK, N.J., May 2, 2023 /PRNewswire-PRWeb/ -- New Jersey Community Capital (NJCC), the state's largest community development financial institution (CDFI), is pleased to welcome Dr. Paul Alexander to the organization's board of directors. Dr. Alexander is currently Executive Vice President, Chief Health Equity and Transformation Officer at RWJBarnabas Health, where he is responsible for the health system's social mission developing strategies to promote the health and wellness of the communities served, including employees. He was recently recognized as a Black healthcare leader to know by Becker's Hospital Review.

Key Points: 
  • NEW BRUNSWICK, N.J., May 2, 2023 /PRNewswire-PRWeb/ -- New Jersey Community Capital (NJCC) , the state's largest community development financial institution (CDFI), is pleased to welcome Dr. Paul Alexander to the organization's board of directors.
  • Dr. Alexander is currently Executive Vice President, Chief Health Equity and Transformation Officer at RWJBarnabas Health, where he is responsible for the health system's social mission developing strategies to promote the health and wellness of the communities served, including employees.
  • His knowledge and understanding of community health will greatly support the work NJCC is leading in the community and industry," said Bernel Hall, President and CEO of NJCC.
  • "Dr. Alexander's expertise and experience working in health care and health insurance adds an invaluable perspective to our board.

Monogram Health Donates $2.5M to University of Pennsylvania for Clinical Research Partnership Aimed at Improving Outcomes for People with Chronic Kidney Disease

Retrieved on: 
Tuesday, September 13, 2022
Health policy, Adoption, Health, Chronic kidney disease, University, Einstein Medical Center Philadelphia, Hospital, University of Pennsylvania Health System, Fellows, Kidney disease, CKD, Wharton School of the University of Pennsylvania, Health equity, Patient, TPG Capital, Leonard Davis Institute of Health Economics, Quality of life, Doctor of Philosophy, African Americans, Norwest Venture Partners, Monogram, Research, LDI, Penn, Color, Disease management, Transplant, Pharmaceutical industry

The donation will be used to establish the Monogram Health Chronic Kidney Disease Fund, which will support a collaborative research initiative at Penn LDI aimed at improving clinical outcomes of individuals with chronic kidney disease.

Key Points: 
  • The donation will be used to establish the Monogram Health Chronic Kidney Disease Fund, which will support a collaborative research initiative at Penn LDI aimed at improving clinical outcomes of individuals with chronic kidney disease.
  • Penn LDI, located in Philadelphia, is dedicated to data-driven, policy-focused research that improves the nation's health and health care.
  • The new Research Initiative on Improving Management of Chronic Kidney Disease will tap into Penn LDI's expertise and reputation as an unbiased academic authority on innovating and improving health care delivery while aligning with Monogram Health's commitment to measurably improve outcomes for individuals living with kidney disease.
  • Monogram Health is a leading value-based provider of in-home nephrology, primary care, and benefit management services for individuals with chronic kidney and end-stage renal disease.

CD&R Announces Anand Shah, M.D., Former FDA Deputy Commissioner, as Operating Advisor

Retrieved on: 
Thursday, February 3, 2022
Associate Director of National Intelligence and Chief Information Officer, Duke University School of Medicine, Patient, UDG Healthcare, Therapy, CMS, Public health, Food, Food and Drug Administration, Publication, Clayton, Dubilier & Rice, University, Policy, Center, CD&R, National, The New England Journal of Medicine, Nature Reviews Drug Discovery, Drug discovery, R, Columbia University, JAMA, Africa/Harvard School of Public Health Partnership for Cohort Research and Training, Centers for Medicare & Medicaid Services, Health policy, Efficiency, Medicare, COVID-19, Medicine, Bureau of Oceans and International Environmental and Scientific Affairs, Company, Dubilier, Leonard Davis Institute of Health Economics, Duke University, Investment, Advanced manufacturing, FDA, Health, Federation, Multimedia, CD, Economics, Hero, Pharmaceutical industry, Cancer

NEW YORK, Feb. 3, 2022 /PRNewswire/ --Clayton, Dubilier & Rice today announced Anand Shah, M.D., former U.S. Food and Drug Administration ("FDA") Deputy Commissioner for Medical and Scientific Affairs, as an Operating Advisor to CD&R funds.

Key Points: 
  • NEW YORK, Feb. 3, 2022 /PRNewswire/ --Clayton, Dubilier & Rice today announced Anand Shah, M.D., former U.S. Food and Drug Administration ("FDA") Deputy Commissioner for Medical and Scientific Affairs, as an Operating Advisor to CD&R funds.
  • Dr. Shah will work with CD&R's healthcare team to source new investments and advise the funds' healthcare businesses.
  • At the FDA, he led consensus policy development for fit-for-purpose programs, including Advanced Manufacturing, vaccine development, digital health, consumer protection, and decentralized clinical trials.
  • During the COVID-19 pandemic, Dr. Shah guided the FDA's policy development for preparedness and recovery efforts.

Researchers from CHOP, Penn receive $5.3 million grant to reduce unnecessary hospital monitoring practices

Retrieved on: 
Tuesday, October 5, 2021
Pediatric Research, National Heart, Lung, and Blood Institute, Children's Hospital, Clinical trial, Infant, Research, Hope, Bronchiolitis, Fatigue, Pediatrics, CHOP, Health, Leonard Davis Institute of Health Economics, University, Hospital, Respiratory tract, EMO, Health policy, Philadelphia, Patient, Children's Hospital of Philadelphia, MD, Feedback, Method, Evidence-based practice, Center, MSCE, Patient safety, Associate, Disease, PRIS, Risk, Science, NHLBI, EHR, Doctor of Philosophy, Lung, Pharmaceutical industry, Medicine

The goal is to reduce these commonplace practices that are currently unsupported by evidence, save patients and hospitals from the burden of unnecessary expenses, and focus on more effective methods of monitoring pediatric health.

Key Points: 
  • The goal is to reduce these commonplace practices that are currently unsupported by evidence, save patients and hospitals from the burden of unnecessary expenses, and focus on more effective methods of monitoring pediatric health.
  • Deimplementation studies seek to reduce practices that are overused by clinicians, especially those known to have little or no evidence of benefit.
  • Bronchiolitis is the leading cause of infant hospitalization, sending more than 100,000 babies to the hospital each year and resulting in about $1.7 billion in charges annually.
  • About Children's Hospital of Philadelphia: Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital.

Equality Health Appoints Andy Slavitt to Board of Directors

Retrieved on: 
Thursday, September 30, 2021
Science, USA Today, Policy, Centers for Medicare & Medicaid Services, Optum, Leonard Davis Institute of Health Economics, University, Health, United States Health Care Reform: Progress to Date and Next Steps, USA, Wharton School of the University of Pennsylvania, Medicaid, Income, Multimedia, Medicare, Fox, CMS, Population, LinkedIn, University of the Philippines College of Arts and Sciences, Center for Medicare and Medicaid Innovation, Twitter, CEO, Acquisition, Equalize Health, LLC, Center, Growth, Modern Healthcare, Harvard Business School, Leadership, Triple accreditation, COVID-19, Bipartisan Policy Center, Plague, View, MBA, Wendell Pritchett, MSNBC, College, CNN, UnitedHealth Group, Pharmaceutical industry, Medicine, Health insurance

"We're excited to welcome Andy to our board during a time of significant growth and changeboth for Equality Health and the healthcare system as a whole," said Hugh Lytle, founder and chief executive officer of Equality Health.

Key Points: 
  • "We're excited to welcome Andy to our board during a time of significant growth and changeboth for Equality Health and the healthcare system as a whole," said Hugh Lytle, founder and chief executive officer of Equality Health.
  • He is currently board chair of United States of Care, a national non-profit health advocacy organization he founded.
  • He is a Distinguished Health Policy Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania.
  • For more information about Equality Health, visit www.equalityhealth.com or follow @EqualityHealth on Facebook, @EqualityHealth on Twitter, and @EqualityHealth on LinkedIn.